Reg3b deficiency impairs pancreatic tumor growth by skewing macrophage polarization

Cancer Research

Volumn 73, Issue 18, 2013, Pages 5682-5694

  Gironella, Meritxell ^a   Calvo, Carlos ^b   Fernéz, Anna ^b   Closa, Daniel ^b   Iovanna, Juan L ^c   Rosello Catafau, Joan ^b   Folch Puy, Emma ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; PROTEIN REG3BETA; SECRETORY PROTEIN; STAT3 PROTEIN; TUMOR PROMOTER; UNCLASSIFIED DRUG; MESSENGER RNA; PAP PROTEIN, MOUSE; PROTEIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL INFILTRATION; CELL VIABILITY; ENZYME ACTIVATION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREAS TUMOR; POLARIZATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; TUMOR MICROENVIRONMENT; UPREGULATION; ADENOCARCINOMA; ANIMAL; C57BL MOUSE; CELL PROLIFERATION; CULTURE MEDIUM; DISEASE MODEL; ENZYME IMMUNOASSAY; GENETICS; KNOCKOUT MOUSE; MACROPHAGE; METABOLISM; METASTASIS; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; DISEASE MODELS, ANIMAL; IMMUNOENZYME TECHNIQUES; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PANCREATIC NEOPLASMS; PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

EID: 84884808494     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-12-3057     Document Type: Article

References (40)

1. Drickamer K. Increasing diversity of animal lectin structures. Curr Opin Struct Biol 1995;5:612-6.
2. Narushima Y, Unno M, Nakagawara K, Mori M, Miyashita H, Suzuki Y, et al. Structure, chromosomal localization and expression of mouse genes encoding type III Reg, RegIII alpha, RegIII beta, RegIII gamma. Gene 1997;185:159-68.
3. Keim V, Loffler HG. Pancreatitis-associated protein in bile acidinduced pancreatitis of the rat. Clin Physiol Biochem 1986;4:136-42.
4. Orelle B, Keim V, Masciotra L, Dagorn JC, Iovanna JL. Human pancreatitis- associated protein. Messenger RNA cloning and expression in pancreatic diseases. J Clin Invest 1992;90:2284-91.
5. Gironella M, Iovanna JL, Sans M, Gil F, Peñalva M, Closa D, et al. Antiinflammatory effects of pancreatitis associated protein in inflammatory bowel disease. Gut 2005;54:1244-53.
6. Vasseur S, Folch-Puy E, Hlouschek V, Garcia S, Fiedler F, Lerch MM, et al. p8 improves pancreatic response to acute pancreatitis by enhancing the expression of the anti-inflammatory protein pancreatitis-associated protein I. J Biol Chem 2004;279: 7199-207.
7. Zhang H, Kandil E, Lin YY, Levi G, Zenilman ME. Targeted inhibition of gene expression of pancreatitis-associated proteins exacerbates the severity of acute pancreatitis in rats. Scand J Gastroenterol 2004; 39:870-81.
8. Gironella M, Folch-Puy E, LeGoffic A, Garcia S, Christa L, Smith A, et al. Experimental acute pancreatitis in PAP/HIP knock-out mice. Gut 2007;56:1091-7.
9. Christa L, Simon MT, Brezault-Bonnet C, Bonte E, Carnot F, Zylberberg H, et al. Hepatocarcinoma-intestine-pancreas/pancreatic associated protein (HIP/PAP) is expressed and secreted by proliferating ductules as well as by hepatocarcinoma and cholangiocarcinoma cells. Am J Pathol 1999;155:1525-33.
10. Xie MJ, Motoo Y, Iovanna JL, Su SB, Ohtsubo K, Matsubara F, et al. Overexpression of pancreatitis-associated protein (PAP) in human pancreatic ductal adenocarcinoma. Dig Dis Sci 2003;48:459-64.
11. Motoo Y, Satomura Y, Mouri I, Mouri H, Ohtsubo K, Sakai J, et al. Serum levels of pancreatitis-associated protein in digestive diseases with special reference to gastrointestinal cancers. Dig Dis Sci 1999;44: 1142-7.
12. Simon MT, Pauloin A, Normand G, Lieu HT, Mouly H, Pivert G, et al. HIP/PAP stimulates liver regeneration after partial hepatectomy and combines mitogenic and anti-apoptotic functions through the PKA signaling pathway. FASEB J 2003;17:1441-50.
13. Hidalgo M. Pancreatic cancer. N Engl J Med 2010;362:1605-17.
14. Li D, Xie K, Wolff R, Abbruzzese JL. Pancreatic cancer. Lancet 2004; 363:1049-57.
15. Gardian K, Janczewska S, Olszewski WL, Durlik M. Analysis of pancreatic cancer microenvironment: role of macrophage infiltrates and growth factors expression. J Cancer 2012;3:285-91.
16. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003;3:23-35.
17. Cerwenka H, Aigner R, Bacher H, Werkgartner G, el-Shabrawi A, Quehenberger F, et al. Pancreatitis-associated protein (PAP) in patients with pancreatic cancer. Anticancer Res 2001;21: 1471-4.
18. Lieu HT, Simon MT, Nguyen-Khoa T, Kebede M, Cortes A, Tebar L, et al. Reg2 inactivation increases sensitivity to Fas hepatotoxicity and delays liver regeneration post-hepatectomy in mice. Hepatology 2006;44:1452-64.
19. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010;140:883-99.
20. Benoit M, Desnues B, Mege JL. Macrophage polarization in bacterial infections. J Immunol 2008;181:3733-9.
21. Hodge S, Matthews G, Mukaro V, Ahern J, Shivam A, Hodge G, et al. Cigarette smoke-induced changes to alveolar macrophage phenotype and function are improved by treatment with procysteine. Am J Respir Cell Mol Biol 2011;44:673-81.
22. Chiang CS, Chen FH, Hong JH, Jiang PS, Huang HL, Wang CC, et al. Functional phenotype of macrophages depends on assay procedures. Int Immunol 2008;20:215-22.
23. Zhang L, Alizadeh D, Van Handel M, Kortylewski M, Yu H, Badie B. Stat3 inhibition activates tumor macrophages and abrogates glioma growth in mice. Glia 2009;57:1458-67.
24. Fujiwara Y, Komohara Y, Kudo R, Tsurushima K, Ohnishi K, Ikeda T, et al. Oleanolic acid inhibits macrophage differentiation into the M2 phenotype and glioblastoma cell proliferation by suppressing the activation of STAT3. Oncol Rep 2011;26:1533-7.
25. Yang M, Zheng J, Miao Y, Wang Y, Cui W, Guo J , et al. Serumglucocorticoid regulated kinase 1 regulates alternatively activated macrophage polarization contributing to angiotensin II-induced inflammation and cardiac fibrosis. Arterioscler Thromb Vasc Biol 2012;32:1675-86.
26. Motoo Y, Itoh T, Su SB, Nakatani MT, Watanabe H, Okai T, et al. Expression of pancreatitis-associated protein (PAP) mRNA in gastrointestinal cancers. Int J Pancreatol 1998;23:11-6.
27. Christa L, Carnot F, Simon MT, Levavasseur F, Stinnakre MG, Lasserre C, et al. HIP/PAP is an adhesive protein expressed in hepatocarcinoma, normal Paneth, and pancreatic cells. Am J Physiol 1996;271(6 Pt 1):G993-G1002.
28. Bartoli C, Baeza N, Figarella C, Pellegrini I, Figarella-Branger D. Expression of peptide-23/pancreatitis-associated protein and Reg genes in human pituitary and adenomas: comparison with other fetal and adult human tissues. J Clin Endocrinol Metab 1998;83:4041-6.
29. Buchler P, Reber HA, Buchler MW, Friess H, Hines OJ. VEGF-RII influences the prognosis of pancreatic cancer. Ann Surg 2002;236: 738-49.
30. Seo Y, Baba H, Fukuda T, Takashima M, Sugimachi K. High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma. Cancer 2000;88:2239-45.
31. Esposito I, Menicagli M, Funel N, Bergmann F, Boggi U, Mosca F, et al. Inflammatory cells contribuye to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma. J Clin Pathol 2004;57:630-6.
32. Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty P, Massobrio M, Regnani G, et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 2003;348:201-11.
33. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pagés C, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006;313: 1960-4.
34. Rosty C, Christa L, Kuzdzal S, Baldwin WM, Zahurak ML, Carnot F, et al. Identification of hepatocarcinoma-intestine-pancreas/pancreatitis- associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. Cancer Res 2002;62: 1868-75.
35. Fukushima N, Koopmann J, Sato N, Prasad N, Carvalho R, Leach SD, et al. Gene expression alterations in the non-neoplastic parenchyma adjacent to infitrating pancreatic ductal adenocarcinoma. Mod Pathol 2005;18:779-87.
36. Folch-Puy E, Granell S, Dagorn JC, Iovanna JL, Closa D. Pancreatitisassociated protein I suppresses NF-kappa B activation through a JAK/ STAT-mediated mechanism in epithelial cells. J Immunol 2006;176: 3774-9.
37. Yoshikawa K, Mitsunaga S, Kinoshita T, Konishi M, Takahashi S, Gotohda N, et al. Impact of tumor-associated macrophages on invasive ductal carcinoma of the pancreas head. Cancer Sci 2012;103: 2012-20.
38. Benson DD, Meng X, Fullerton DA, Moore EE, Lee JH, Ao L, et al. Activation state of stromal inflammatory cells in murine metastatic pancreatic adenocarcinoma. Am J Physiol Regul Integr Comp Physiol 2012;302:R1067-75.
39. Kurahara H, Shinchi H, Mataki Y, Maemura K, Noma H, Kubo F, et al. Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. J Surg Res 2011;167:e211-9.
40. Malka D, Vasseur S, Bodeker H, Ortiz EM, Dusetti NJ, Verrando P, et al. Tumor necrosis factor alpha triggers antiapoptotic mechanisms in rat pancreatic cells through pancreatitis-associated protein I activation. Gastroenterology 2000;119:816-28.